The Trump administration announced a deal with Eli Lilly and Novo Nordisk to lower the costs of GLP-1 medications, which may ...

President Trump promised to lower the cost of Ozempic to $150. Mark Cuban says he's working from the same playbook as Cost ...

The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.

Key Takeaways Medicare and Medicaid will cover drugs used for weight loss for the first time, offering Wegovy, Zepbound, Monjauro, and Ozempic for $50 a month co-pays.The White House negotiated lower ...

TrumpRx.com is currently unavailable minutes after President Donald Trump announced it as a portal for newly discounted weight loss drugs Wegovy and Zepbound.

Trump administration strikes deal with Novo Nordisk and Eli Lilly to slash weight-loss drug costs. Wegovy starting doses drop ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

President Trump will announce concessions from Eli Lilly and Novo Nordisk that would lower the price of some of the companies ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...

The National Healthcare Institute is looking into adding another two obesity medications to the basic health insurance ...